CM Hospitalar S/A Stock

Equities

VVEO3

BRVVEOACNOR0

Pharmaceuticals

Market Closed - Sao Paulo 04:06:00 2024-05-10 pm EDT 5-day change 1st Jan Change
3.53 BRL -44.61% Intraday chart for CM Hospitalar S/A -34.87% -74.70%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 12.06B 2.34B Sales 2025 * 13.24B 2.57B Capitalization 1.13B 219M
Net income 2024 * 262M 50.82M Net income 2025 * 401M 77.78M EV / Sales 2024 * 0.32 x
Net Debt 2024 * 2.75B 534M Net Debt 2025 * 2.46B 478M EV / Sales 2025 * 0.27 x
P/E ratio 2024 *
3.76 x
P/E ratio 2025 *
3.08 x
Employees 6,000
Yield 2024 *
7.92%
Yield 2025 *
10.1%
Free-Float 47.47%
More Fundamentals * Assessed data
Dynamic Chart
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
CM Hospitalar S/A(BOVESPA:VVEO3) added to Brazil Small Cap Index CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022 CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022 CI
CM Hospitalar S/A acquired remaining stake in Far.me. CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
CM Hospitalar S/A agreed to acquire Neve Industria e Comercio de Produtos Cirurgicos and Nutrifica Comercio de Nutricao Enteral e Parenteral for BRL 110 million. CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
More news
1 day-44.61%
1 week-34.87%
Current month-29.96%
1 month-48.47%
3 months-58.91%
6 months-76.39%
Current year-74.70%
More quotes
1 week
3.33
Extreme 3.33
5.48
1 month
3.33
Extreme 3.33
6.97
Current year
3.33
Extreme 3.33
14.09
1 year
3.33
Extreme 3.33
22.61
3 years
3.33
Extreme 3.33
27.90
5 years
3.33
Extreme 3.33
27.90
10 years
3.33
Extreme 3.33
27.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 21-08-24
Director of Finance/CFO 44 19-01-31
Chief Operating Officer 53 10-12-31
Members of the board TitleAgeSince
Director/Board Member 44 22-04-28
Chairman 45 15-12-31
Director/Board Member 45 22-07-31
More insiders
Date Price Change Volume
24-05-10 3.53 -19.77% 12,470,700
24-05-09 4.4 -1.35% 2,256,600
24-05-08 4.46 -3.46% 2,240,400
24-05-07 4.62 -1.07% 1,916,800
24-05-06 4.67 -13.84% 4,044,400

Delayed Quote Sao Paulo, May 10, 2024 at 04:06 pm EDT

More quotes
CM Hospitalar SA, formerly known as a CM Hospitalar Ltda, is a Brazil-based public company which engages in the wholesale trade of medicines, drugs, and hospital supplies. The Company operates mainly in export, import, production, representation, storage, distribution, and shipment of medicines, including special control and wholesale trade in general, acting mainly in the trade in health products, as a middleman between industries and hospitals, clinics, home cares and health institutions in the private and public market, in addition to participating in other investments. It operates throughout Brazil with a commercial and logistical structure. The Company's medium and long-term planning encompasses the acquisition of companies from the segment and an important commercial strengthening throughout Brazil, expanding its position in the distribution of medicines and hospital supplies.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
3.53 BRL
Average target price
15.33 BRL
Spread / Average Target
+334.37%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW